References
Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57–70.
Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006;124:263–6.
Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001;344:783–92
Piccart-Gebhart MJ, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 2005;353:1659–72.
Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell 2006;124:471–84.
Karin M, Cao Y, Greten FR, Li ZW. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002;2:301–10.
Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ, et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004;118:285–96.
Wiener Z, Ontsouka EC, Jakob S, Torgler R, Falus A, Mueller C, et al. Synergistic induction of the Fas (CD95) ligand promoter by Max and NFkappaB in human non-small lung cancer cells. Exp Cell Res 2004;299:227–35.
Robbins J, Blondel BJ, Gallahan D, Callahan R. Mouse mammary tumor gene int-3: a member of the notch gene family transforms mammary epithelial cells. J Virol 1992;66:2594–99.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hynes, N.E., Gullick, W. Therapeutic Targeting of Signal Transduction Pathways and Proteins in Breast Cancer. J Mammary Gland Biol Neoplasia 11, 1–2 (2006). https://doi.org/10.1007/s10911-006-9007-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10911-006-9007-3